Selective targeting of M‐type potassium Kv7.4 channels demonstrates their key role in the regulation of dopaminergic neuronal excitability and depression‐like behaviour
暂无分享,去创建一个
Li Li | Hui Sun | Xiaona Du | N. Gamper | Ludi Zhang | Hailin Zhang | Hailin Zhang | Nikita Gamper | Ludi Zhang | Hui Sun | Xiaona Du | Chuan Wang | Jie Ding | Chenxu Niu | Min Su | Yingmin Li | Chuan Wang | Chenxu Niu | Li Li | Jie Ding | Yingmin Li | Min Su
[1] Christopher Southan,et al. The Concise Guide to PHARMACOLOGY 2015/16: Enzymes , 2015, British journal of pharmacology.
[2] D. Brown,et al. Neural KCNQ (Kv7) channels , 2009, British journal of pharmacology.
[3] J. Bolam,et al. Uniform Inhibition of Dopamine Neurons in the Ventral Tegmental Area by Aversive Stimuli , 2004, Science.
[4] N. Tsuchimori,et al. Activation of peripheral KCNQ channels attenuates inflammatory pain , 2014, Molecular pain.
[5] Ming-Hu Han,et al. Diversity of Dopaminergic Neural Circuits in Response to Drug Exposure , 2016, Neuropsychopharmacology.
[6] Aaron S. Andalman,et al. Dopamine neurons modulate neural encoding and expression of depression-related behaviour , 2012, Nature.
[7] W. Schultz. Multiple dopamine functions at different time courses. , 2007, Annual review of neuroscience.
[8] Joanna L. Sharman,et al. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands , 2015, Nucleic Acids Res..
[9] T. Jentsch. Neuronal KCNQ potassium channels:physislogy and role in disease , 2000, Nature Reviews Neuroscience.
[10] A. Zangen,et al. Dissociation between Rewarding and Psychomotor Effects of Opiates: Differential Roles for Glutamate Receptors within Anterior and Posterior Portions of the Ventral Tegmental Area , 2008, The Journal of Neuroscience.
[11] B S Brown,et al. KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. , 1998, Science.
[12] Jochen Roeper,et al. Ih Channels Contribute to the Different Functional Properties of Identified Dopaminergic Subpopulations in the Midbrain , 2002, The Journal of Neuroscience.
[13] George Paxinos,et al. The Mouse Brain in Stereotaxic Coordinates , 2001 .
[14] T. Kosten,et al. Acute stress diminishes M-current contributing to elevated activity of hypothalamic-pituitary-adrenal axis , 2017, Neuropharmacology.
[15] Ming-Hu Han,et al. KCNQ channel openers reverse depressive symptoms via an active resilience mechanism , 2016, Nature Communications.
[16] A. Gershon,et al. Dopamine D2-Like Receptors and the Antidepressant Response , 2007, Biological Psychiatry.
[17] D. Overstreet,et al. The Flinders Sensitive Line Rat Model of Depression—25 Years and Still Producing , 2013, Pharmacological Reviews.
[18] Vincent Seutin,et al. The KCNQ Channel Opener Retigabine Inhibits the Activity of Mesencephalic Dopaminergic Systems of the Rat , 2006, Journal of Pharmacology and Experimental Therapeutics.
[19] Stephen R. Williams,et al. Errors in the measurement of voltage-activated ion channels in cell-attached patch-clamp recordings , 2011, Nature communications.
[20] Scott J. Russo,et al. Molecular Adaptations Underlying Susceptibility and Resistance to Social Defeat in Brain Reward Regions , 2007, Cell.
[21] J. Bolam,et al. Stereological estimates of dopaminergic, GABAergic and glutamatergic neurons in the ventral tegmental area, substantia nigra and retrorubral field in the rat , 2008, Neuroscience.
[22] M. Wong,et al. Research and treatment approaches to depression , 2001, Nature Reviews Neuroscience.
[23] Christopher Southan,et al. The Concise Guide to PHARMACOLOGY 2015/16: Ligand‐gated ion channels , 2015, British journal of pharmacology.
[24] S. B. Appel,et al. Characterization of M-current in ventral tegmental area dopamine neurons. , 2006, Journal of neurophysiology.
[25] Manoj Kumar,et al. Synthesis and Evaluation of Potent KCNQ2/3-Specific Channel Activators , 2016, Molecular Pharmacology.
[26] D. A. Brown,et al. Activation of Expressed KCNQ Potassium Currents and Native Neuronal M-Type Potassium Currents by the Anti-Convulsant Drug Retigabine , 2001, The Journal of Neuroscience.
[27] C. Heurteaux,et al. Retroinverso analogs of spadin display increased antidepressant effects , 2014, Psychopharmacology.
[28] R. Leuwer,et al. Mice with altered KCNQ4 K+ channels implicate sensory outer hair cells in human progressive deafness , 2006, The EMBO journal.
[29] A. Grace,et al. Regulation of firing of dopaminergic neurons and control of goal-directed behaviors , 2007, Trends in Neurosciences.
[30] K. Deisseroth,et al. Phasic Firing in Dopaminergic Neurons Is Sufficient for Behavioral Conditioning , 2009, Science.
[31] Philippe Faure,et al. Hierarchical Control of Dopamine Neuron-Firing Patterns by Nicotinic Receptors , 2006, Neuron.
[32] Christopher Southan,et al. The Concise Guide to PHARMACOLOGY 2015/16: Voltage‐gated ion channels , 2015, British journal of pharmacology.
[33] G. Debonnel,et al. Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype , 2006, Nature Neuroscience.
[34] M. Trudeau,et al. Handbook of ion channels , 2015 .
[35] Paul A Insel,et al. Experimental design and analysis and their reporting: new guidance for publication in BJP , 2015, British journal of pharmacology.
[36] C. Nemeroff,et al. The role of dopamine in the pathophysiology of depression. , 2007, Archives of general psychiatry.
[37] Yuan-yuan Zhang,et al. Selective activation of vascular Kv7.4/Kv7.5 K+ channels by fasudil contributes to its vasorelaxant effect , 2016, British journal of pharmacology.
[38] C. Leonard,et al. Direct and Indirect Excitation of Laterodorsal Tegmental Neurons by Hypocretin/Orexin Peptides: Implications for Wakefulness and Narcolepsy , 2002, The Journal of Neuroscience.
[39] K. Deisseroth,et al. Rapid regulation of depression-related behaviors by control of midbrain dopamine neurons , 2012, Nature.
[40] Vincent Seutin,et al. Kv7 channels: interaction with dopaminergic and serotonergic neurotransmission in the CNS , 2008, The Journal of physiology.
[41] Kelly R. Tan,et al. Methamphetamine-Evoked Depression of GABAB Receptor Signaling in GABA Neurons of the VTA , 2012, Neuron.
[42] E. Chevet,et al. Spadin, a Sortilin-Derived Peptide, Targeting Rodent TREK-1 Channels: A New Concept in the Antidepressant Drug Design , 2010, PLoS biology.
[43] Ming-Hu Han,et al. The heterogeneity of ventral tegmental area neurons: Projection functions in a mood-related context , 2014, Neuroscience.
[44] C. Lüscher,et al. Cocaine Exposure Enhances the Activity of Ventral Tegmental Area Dopamine Neurons via Calcium-Impermeable NMDARs , 2016, The Journal of Neuroscience.
[45] C. Heurteaux,et al. Targeting two‐pore domain K+ channels TREK‐1 and TASK‐3 for the treatment of depression: a new therapeutic concept , 2015, British journal of pharmacology.
[46] Maxime Bonjean,et al. M-type channels selectively control bursting in rat dopaminergic neurons , 2010, The European journal of neuroscience.
[47] I. Cuthill,et al. Animal Research: Reporting In Vivo Experiments: The ARRIVE Guidelines , 2010, British journal of pharmacology.
[48] Shuh Narumiya,et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension , 1997, Nature.
[49] P. Slesinger,et al. Sorting Nexin 27 Regulation of G Protein-Gated Inwardly Rectifying K+ Channels Attenuates In Vivo Cocaine Response , 2014, Neuron.
[50] R. Neve,et al. Enhancing Depression Mechanisms in Midbrain Dopamine Neurons Achieves Homeostatic Resilience , 2014, Science.
[51] John C McGrath,et al. Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP , 2015, British journal of pharmacology.
[52] E. Nestler,et al. Mesolimbic Dopamine Neurons in the Brain Reward Circuit Mediate Susceptibility to Social Defeat and Antidepressant Action , 2010, The Journal of Neuroscience.